AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-2.38%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.22B
AUM Growth
+$1.22B
(+5.6%)
Cap. Flow
+$27.4M
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
93
New
22
Increased
25
Reduced
17
Closed
18
Top Buys
| 1 |
United Therapeutics
UTHR
|
$37.3M |
| 2 |
Avis
CAR
|
$32.1M |
| 3 |
Ralph Lauren
RL
|
$30M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$29.7M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$28.4M |
Top Sells
| 1 |
SGI
Somnigroup International Inc.
SGI
|
$40M |
| 2 |
United Parks & Resorts
PRKS
|
$34.4M |
| 3 |
CVS Health
CVS
|
$31.5M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$30.4M |
| 5 |
Incyte
INCY
|
$28.7M |
Sector Composition
| 1 | Healthcare | 50.4% |
| 2 | Consumer Discretionary | 26.38% |
| 3 | Consumer Staples | 10.32% |
| 4 | Industrials | 3.07% |
| 5 | Communication Services | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $81.7M | 4.91% | 17,500,400 +1,086,000 | +7% | +$5.07M |
|
2
J.M. Smucker
SJM
$11.8B
| $52.9M | 3.18% | 516,000 +192,000 | +59% | +$19.7M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $48M | 2.88% | 1,636,000 +1,012,000 | +162% | +$29.7M |
|
4
Edgewell Personal Care
EPC
$1.12B
| $46.2M | 2.78% | 1,000,000 -92,000 | -8% | -$4.25M |
|
|
MNK
5
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $45.1M | 2.71% | 1,540,000 -860,000 | -36% | -$25.2M |
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $41.6M | 2.5% | 2,080,000 | – | – |
|
|
7
Enanta Pharmaceuticals
ENTA
$180M
| $39M | 2.34% | 456,000 +332,000 | +268% | +$28.4M |
|
|
PGNX
8
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $38.6M | 2.32% | 6,158,000 +3,622,000 | +143% | +$22.7M |
|
|
9
United Therapeutics
UTHR
$13.8B
| $37.3M | 2.24% | +292,000 | New | +$37.3M |
|
10
Harley-Davidson
HOG
$3.54B
| $37.3M | 2.24% | 824,000 -176,000 | -18% | -$7.97M |
|
11
Hanesbrands
HBI
$2.23B
| $36.9M | 2.21% | 2,000,000 +720,000 | +56% | +$13.3M |
|
12
Capri Holdings
CPRI
$2.45B
| $36.7M | 2.21% | 536,000 +118,000 | +28% | +$8.09M |
|
13
Voyager Therapeutics
VYGR
$186M
| $32.6M | 1.96% | 1,724,000 +1,292,000 | +299% | +$24.4M |
|
|
PLYA
14
DELISTED
Playa Hotels & Resorts
PLYA
| $32.3M | 1.94% | 3,352,000 +416,000 | +14% | +$4.01M |
|
|
15
Avis
CAR
$5.57B
| $32.1M | 1.93% | +1,000,000 | New | +$32.1M |
|
|
DFRG
16
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $31.2M | 1.87% | 3,756,000 +2,756,000 | +276% | +$22.9M |
|
|
ATRS
17
DELISTED
Antares Pharma, Inc.
ATRS
| $30.6M | 1.84% | 9,120,000 -2,930,000 | -24% | -$9.84M |
|
18
Regeneron Pharmaceuticals
REGN
$61.5B
| $30.3M | 1.82% | 75,000 -53,000 | -41% | -$21.4M |
|
|
19
Ralph Lauren
RL
$18B
| $30M | 1.8% | +218,000 | New | +$30M |
|
20
Hain Celestial
HAIN
$162M
| $27.1M | 1.63% | +1,000,000 | New | +$27.1M |
|
|
DESP
21
DELISTED
Despegar.com
DESP
| $26.4M | 1.58% | 1,564,000 -28,000 | -2% | -$472K |
|
22
Light & Wonder
LNW
$7.76B
| $22.9M | 1.37% | 900,000 +532,000 | +145% | +$13.5M |
|
|
23
Vanda Pharmaceuticals
VNDA
$279M
| $20.7M | 1.24% | 900,000 -1,324,000 | -60% | -$30.4M |
|
|
QVCGA
24
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $20M | 1.2% | 900,000 +410,000 | +84% | +$9.11M |
|
25
Assertio
ASRT
$80.4M
| $17.6M | 1.06% | 3,000,000 +1,822,100 | +155% | +$10.7M |
|